AAO 2018 Speakers
Andrew Gitkin is a managing director and head of West Coast biotechnology investment banking at Piper Jaffray. Mr. Gitkin has 20+ years of experience, most…
Read MoreEllie Chabi, MD is the Therapeutic Area Head for Glaucoma & Neuroprotection as well as the Lead for Artificial Intelligence Programs within Global Biomedical Science…
Read MoreMitul is a cofounder of Eyedaptic and a board-certified ophthalmologist with fellowship training in medical and surgical diseases of the retina at UCI’s Gavin Herbert…
Read MoreAdam Rogers is the CEO and Co-Founder of Hemera Biosciences, a clinical stage company treating retinal diseases with gene therapy.
Read MoreCharles has 17 years of clinical drug development experience in retina, ocular surface disease, and glaucoma. He held senior leadership positions at Genentech, Shire, SARcode…
Read MorePatrik De Haes, MD, has over 25 years of experience in the global healthcare industry in product development, marketing and general management. Before joining Oxurion…
Read MoreDale Wiggins is Vice President and General Manager of the Philips HealthSuite Digital Platform. The HealthSuite Digital Platform (HSDP) is the center for first time…
Read MoreAndrew is responsible for the US Commercial Retina Business at Allergan and is located in Irvine, CA. Prior to joining the Commercial Team, Andrew was…
Read MoreRamin Valian has over two decades of sales leadership, marketing and strategic planning experience in the specialty pharmaceutical and biotech business, and over 13 years’…
Read MoreAndrew Levien is Chief Executive Officer and director of ArcScan and has been with the company since 2009 and as CEO since 2012. Over the…
Read MoreDavid Eveleth is currently CEO of Trefoil Therapeutics. Previously he was a consultant to several biotechnology companies and venture capital groups. Prior to this, David…
Read MoreDr. Lawrence is a co-founder of the company and co-inventor of the company’s SDP technology. He has over 12 years’ experience in developing silk-based biomaterials…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.